[Neosalvarsan, atropine sulfate and trypaflavin in subcutaneously injected rats: absence of cancerigenic effect of the first two and induced sarcoma in the site of trypaflavin injection].
D000818:Animals; D001153:Arsphenamine / Q000031:analogs & derivatives; D001285:Atropine; D001286:Atropine Derivatives; D005415:Flavins; D007267:Injections; D007279:Injections, Subcutaneous; D051381:Rats; D012509:Sarcoma; D012513:Sarcoma, Experimental
D001286:Atropine Derivatives; D005415:Flavins; D001153:Arsphenamine; D001285:Atropine; C073331:neoarsphenamine
ARSPHENAMINES; ATROPINE/derivatives; FLAVINS; SARCOMA/experimental
Neosalvarsán, sulfato de atropin a y tripaflavina en ratas inyectadas subcutáneamente: carencia de poder cancerägeno de los d os primeros y producción de un sarcoma en el lugar de la inyección de tripaflavina.